These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5616116)

  • 1. [Aspects of cortisol metabolism in liver diseases].
    Della Casa L; Boni M
    Endocrinol Sci Cost; 1967 Nov; 29(5):344-53. PubMed ID: 5616116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-prognostic significance of plasma cortisol half-life(after intravenous administration ) during acute and chronic hepatic diseases].
    Del Prete S; Malacco E; Bonzi G; Natelli A; Roncoroni S; Jalanbo H
    Minerva Med; 1975 Mar; 66(22):1051-7. PubMed ID: 1124151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 4. Cortisol metabolism in liver cirrhosis.
    Scavo D; Cugini P; Di Lascio G; Lupi A; Rossi G
    Folia Endocrinol; 1974 Dec; 27(6pt2):670-7. PubMed ID: 4480665
    [No Abstract]   [Full Text] [Related]  

  • 5. [The liver and hormonal steroids. Physiological and pathological problems].
    Bercovici JP; Mauvais-Jarvis P
    Pathol Biol (Paris); 1972 Mar; 20(5):305-14. PubMed ID: 4556215
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of theophylline in patients with liver diseases.
    Staib AH; Schuppan D; Lissner R; Zilly W; von Bomhard G; Richter E
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):500-2. PubMed ID: 7203726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic clearance rate of cortisol in normal subjects and in various disease states.
    Scavo D; Cugini P; Di Lascio G
    J Nucl Med Allied Sci; 1978; 22(3):113-23. PubMed ID: 739279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic changes produced by surgical stress and postoperative liver failure in liver disease patients].
    Fluture V; Onisei O; Lupşa I; Nistor C; Bilegan C; Roştaru M; Mihalaş G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1986; 35(3):221-32. PubMed ID: 2944175
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.
    Kawai S; Ichikawa Y; Homma M
    J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in thyroxine-binding capacity in liver diseases].
    Pottkämper G; Gatz J; Schwinn G; Hesch RD; Köbberling J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():322-5. PubMed ID: 829382
    [No Abstract]   [Full Text] [Related]  

  • 14. [Properdin system and liver diseases].
    Reissmann G
    Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440
    [No Abstract]   [Full Text] [Related]  

  • 15. [D-thyroxine metabolism in hepatic insufficiency].
    Morgner KD; Krüskemper HL; Seifert E
    Verh Dtsch Ges Inn Med; 1969; 75():334-6. PubMed ID: 5400143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent aspects of liver biochemistry: from physiopathology to functional liver exploration].
    Guéchot J; Gerhardt M; Imbert-Bismut F; Jezequel-Cuer M; Myara A; Vassault A; Vaubourdolle M; Voitot H
    Ann Biol Clin (Paris); 1995; 53(7-8):373-94. PubMed ID: 8597308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical and physiological problems rising from the application of the measurement methods of the peripheral metabolism of cortisol (author's transl)].
    Manin M; Delost P
    J Physiol (Paris); 1977 Jun; 73(1):47-72. PubMed ID: 886481
    [No Abstract]   [Full Text] [Related]  

  • 18. The daily rhythm of cortisolemia in hepatic cirrhosis.
    Ruzyllo E; Dzieniszewski J; Milewski B; Krygier T
    Mater Med Pol; 1973; 5(1):9-16. PubMed ID: 4774849
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypnotics and sedatives in liver diseases (summary of session 4)].
    Z Gastroenterol Verh; 1976; (12):203-20. PubMed ID: 73293
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of bile acids and some biliary excreted drugs on the metabolism of cortisol.
    Gerdes H; Riemenschneider H; Littmann KP
    Acta Endocrinol Suppl (Copenh); 1973; 173():10. PubMed ID: 4542050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.